Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$357K Sell
988
-37
-4% -$12.7K 0.02% 471
2026
Q1
$360K Buy
1,025
+272
+36% +$97K 0.03% 419
2025
Q4
$246K Buy
753
+31
+4% +$9.83K 0.02% 446
2025
Q3
$204K Buy
722
+1
+0.1% +$290 0.02% 492
2025
Q2
$201K Buy
+721
New +$204K 0.02% 462
2024
Q4
Sell
-633
Closed -$204K 418
2024
Q3
$204K Buy
+633
New +$207K 0.02% 384

Other funds holding AMGN

Inspire Advisors's AMGN Position: Q2 2026 in Review

Inspire Advisors reduced its Amgen (AMGN) stake by 3.6% in Q2 2026, selling an estimated $12.7K and leaving 988 shares worth $357K. The position accounts for 0.02% of the portfolio, ranked #471.

Inspire Advisors first reported a position in AMGN in Q3 2024 and has held it in 6 quarters since. The position peaked at $360K in Q1 2026. 3,158 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Inspire Advisors held 988 shares of Amgen worth $357K as of Q2 2026.
  • Inspire Advisors sold 37 Amgen shares in Q2 2026, an estimated $12.7K.
  • Amgen made up 0.02% of Inspire Advisors's portfolio in Q2 2026, its #471 holding.
  • Inspire Advisors first reported a position in Amgen in Q3 2024 and has held it in 6 quarters since.
  • Inspire Advisors's Amgen position peaked at $360K in Q1 2026.
  • 3,158 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Inspire Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.